Wednesday, February 10, 2010, 1:25am EST - Canadian Markets open in 8 hours and 5 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Amgen Inc. (AMGN)

 On Feb 9: 57.21 USD  Down 0.25 (0.44%)  
MORE ON AMGN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Amgen Inc. (NasdaqNM:AMGN) Delayed quote dataEdit
After Hours: 57.10 Down 0.11 (0.19%) as of 7:58pm EST on 02/09/10
Last Trade: 57.21 USD
Trade Time: Feb 9
Change: Down 0.25 (0.44%)
Prev Close: 57.46
Open: 58.17
Bid: 57.10 x 1000
Ask: 57.22 x 200
1y Target Est: 68.94
Day's Range: 56.70 - 58.40
52wk Range: 44.96 - 64.76
Volume: 18,732,186
Avg Vol (3m): 6,527,030
Market Cap: 56.92B
P/E (ttm): 12.69
EPS (ttm): 4.51
Div & Yield: N/A (N/A%)
Amgen Inc. (AMGN)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add AMGN to Portfolio   Download Data

HEADLINES
• U.S. Stocks Gain on Hopes for Greece Aid
at The Wall Street Journal Online (Tue 10:09pm)
• Amgen's denosumab offers hope in rare bone tumours
at Reuters (Tue 7:01pm)
• Coca-Cola and industrials help stocks rally
at FT.com (Tue 5:20pm)
• Amgen, Apple: Money Flow Leaders (AMGN, AAPL)
at The Wall Street Journal Online (Tue 4:25pm)
• Dow Over 10,000; Greek Rescue Plan Pondered
at SmartMoney.com (Tue 3:17pm)
• Don't Invest Another Penny
at Motley Fool (Tue 12:41pm)
• Bone Up On This Potential Blockbuster
at Motley Fool (Tue 11:58am)
• Amgen sees positive data in bone drug study
AP (Tue 10:58am)
• Positive Results on Amgen Drug
Zacks.com (Tue 10:49am)
• Indications: U.S. futures recover after sub-10,000 Dow close
at MarketWatch (Tue 8:59am)
• UPDATE - Amgen: denosumab prostate cancer trial meets goals
at Reuters (Mon, Feb 8)
More Headlines for AMGN...
ANALYST
EPS Est (next year) (Dec-10) : 5.15
EPS Est (in 2 years) (Dec-11) : 5.48
Avg Rec (current)*: 1.9
PEG Ratio: 1.27
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Amgen Inc., a biotechnology company, engages in the discovery, development, manufacture, and marketing of human therapeutics based on advances in cellular and molecular biology.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices